From Tech to Deep Tech
from-tech-to-deep-tech
from-tech-to-deep-tech
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Michelin,<br />
Industry Partner<br />
-<br />
Michelin, the leading tire company, is<br />
dedicated <strong>to</strong> enhancing its clients’ mobility,<br />
sustainably; designing and distributing the<br />
most suitable tires, services and solutions for<br />
its clients’ needs; providing digital services,<br />
maps and guides <strong>to</strong> help enrich trips and<br />
travels and make them unique experiences;<br />
and developing high-technology materials<br />
that serve the mobility industry.<br />
Headquartered in Clermont-Ferrand,<br />
France, Michelin is present in 170 countries,<br />
has 111,700 employees and operates 68<br />
production facilities in 17 countries which<br />
<strong>to</strong>gether produced 184 million tires in 2015.<br />
(www.michelin.com)<br />
Roche,<br />
Industry Partner<br />
-<br />
“Roche recognizes the great<br />
value that startups have<br />
in the healthcare sec<strong>to</strong>r.<br />
Since this is a particularly<br />
challenging sec<strong>to</strong>r <strong>to</strong> enter, we<br />
have developed a men<strong>to</strong>ring<br />
program. This program is<br />
provided <strong>to</strong> support startups<br />
by giving them access<br />
<strong>to</strong> experts in a variety of<br />
business units and the startup<br />
remains independent of the<br />
organization. In return, the<br />
Roche men<strong>to</strong>rs are provided<br />
with opportunities <strong>to</strong> learn<br />
more about how entrepreneurs<br />
function and valuable<br />
exposure <strong>to</strong> the innovation<br />
ecosystem which supports an<br />
entrepreneurial spirit within<br />
our organization.”<br />
Padraic Ward,<br />
President of Roche France SAS<br />
Roche is a global pioneer in pharmaceuticals<br />
and diagnostics focused on advancing<br />
science <strong>to</strong> improve people’s lives. The<br />
combined strengths of pharmaceuticals and<br />
diagnostics under one roof have made Roche<br />
the leader in personalised healthcare – a<br />
strategy that aims <strong>to</strong> fit the right treatment<br />
<strong>to</strong> each patient in the best way possible.<br />
Roche is the world’s largest biotech company,<br />
with truly differentiated medicines in<br />
oncology, immunology, infectious diseases,<br />
ophthalmology and diseases of the central<br />
nervous system. Roche is also the world<br />
leader in in vitro diagnostics and tissuebased<br />
cancer diagnostics, and a frontrunner<br />
in diabetes management.<br />
Founded in 1896, Roche continues <strong>to</strong> search<br />
for better ways <strong>to</strong> prevent, diagnose and<br />
treat diseases and make a sustainable<br />
contribution <strong>to</strong> society. The company also<br />
aims <strong>to</strong> improve patient access <strong>to</strong> medical<br />
innovations by working with all relevant<br />
stakeholders. Twenty-nine medicines<br />
developed by Roche are included in the<br />
World Health Organization Model Lists<br />
of Essential Medicines, among them<br />
life-saving antibiotics, antimalarials and<br />
cancer medicines. Roche has been recognised<br />
as the Group Leader in sustainability within<br />
the Pharmaceuticals, Biotechnology &<br />
Life Sciences Industry eight years in a row by<br />
the Dow Jones Sustainability Indices (DJSI).<br />
The Roche Group, headquartered in Basel,<br />
Switzerland, is active in over 100 countries<br />
and in 2016 employed more than 94,000<br />
45